Capouch Samuel D, Farlow Martin R, Brosch Jared R
Department of Neurology, Indiana University School of Medicine, 355 W 16th St #4700, Indianapolis, IN, 46202, USA.
Neurol Ther. 2018 Dec;7(2):249-263. doi: 10.1007/s40120-018-0104-1. Epub 2018 Jul 9.
Dementia with Lewy bodies is one of the most common causes of dementia. It is not as common as Alzheimer's disease; the general public's awareness of the disease is poor in comparison. Its effects on caregivers and patients alike are not well known to the general population. There are currently no FDA-approved medications specifically for the treatment of DLB. Many of the medications that are approved for Alzheimer's disease are widely used in the treatment of DLB with varying degrees of success. Treatment of DLB is life long and requires a dedicated team of physicians and caregivers to minimize the degree of morbidity and mortality experienced by the patients suffering from the disease as it progresses.
路易体痴呆是痴呆最常见的病因之一。它不像阿尔茨海默病那么常见；相比之下，公众对这种疾病的认知度较低。普通大众对其给护理人员和患者带来的影响了解甚少。目前尚无美国食品药品监督管理局（FDA）批准的专门用于治疗路易体痴呆的药物。许多已被批准用于治疗阿尔茨海默病的药物也被广泛用于治疗路易体痴呆，且取得了不同程度的成功。路易体痴呆的治疗是终身的，需要一支专业的医生和护理人员团队，以尽量降低随着疾病进展患者所经历的发病程度和死亡率。
